CYP2D6 and breast cancer: A different result was reported by Kelly et al. as they investigated concurrent intake of CYP2D6 inhibitors with tamoxifen based on overlapping prescribing times, and they found only paroxetine use was linked with an increase in breast cancer and overall mortality [21].